News | March 23, 2015

Fujifilm Features Aspire Cristalle at the 25th Annual Interdisciplinary Breast Center Conference

New features maximize patient comfort while improving ease of use for operator

Fujifilm, Aspire Cristalle, mammography, Breast Center Conference

March 23, 2015 — Fujifilm Medical Systems U.S.A. Inc. showcased the Aspire Cristalle at the 25th Annual Interdisciplinary Breast Center Conference sponsored by the National Consortium of Breast Centers, March 14-18 in Las Vegas.

Fujifilm’s new imaging technology and advanced algorithms provide high-quality imaging of all breast types, including dense breasts and implants, helping to reduce the anxiety of repeat exams and higher-dose procedures. The patented Comfort Paddle is one of many features designed to make mammograms more comfortable and easier to endure for patients.

Aspire Cristalle also makes it easier for technologists to perform exams accurately and quickly. From the one-button startup, to the one-button mirrored positioning, combined with gentle, even compression and automated release features, technologists will find Aspire Cristalle easy to work with. The system combines innovative detector engineering with patient-focused ergonomics, resulting in faster, more confident diagnosis for clinicians and exceptional patient comfort.

For more information:

Related Content

Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...
Hologic Earns CE Mark for LOCalizer Wireless Breast Lesion Localization System
News | Breast Imaging | March 07, 2019
Hologic Inc. announced the granting of a CE Mark to the LOCalizer wireless radio frequency identification (RFID) breast...
South Dakota's Density Inform Bill Signed Into Law
News | Breast Density | March 06, 2019
With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which...
iCAD Partnering With Karolinska Instituet Researchers on AI-based Breast Cancer Risk Prediction
News | Oncology Diagnostics | March 04, 2019
iCAD announced their intent to enter an exclusive relationship with two leading researchers at The Karolinska...

Image courtesy of Hologic.

Feature | Breast Imaging | February 27, 2019 | By Jeff Zagoudis